Bone scan index rise prior to osteonecrosis of the jaw with bone‐modifying agents in prostate cancer

Abstract Objective This study aimed to evaluate the maximum bone scan index in the jaw (BSIJmax) before the development of clinical medication‐related osteonecrosis of the jaw (MRONJ) in patients with prostate cancer. Methods We retrospectively analysed 135 patients with prostate cancer and bone met...

詳細記述

書誌詳細

主要な著者:	Masaru Tani, Koji Hatano, Takashi Kamiya, Masatoshi Konishi, Atsuki Matsukawa, Hiromu Horitani, Syunsuke Inoguchi, Tomohiro Kanaki, Akihiro Yoshimura, Yuki Horibe, Yutong Liu, Nesrine Sassi, Toshiki Oka, Yohei Okuda, Gaku Yamamichi, Yu Ishizuya, Takuji Hayashi, Yoshiyuki Yamamoto, Taigo Kato, Tadashi Watabe, Atsunari Kawashima, Kayako Isohashi, Norio Nonomura
フォーマット:	Artigo
言語:	Inglês
出版事項:	Wiley 2026-05-01
シリーズ:	BJUI Compass
主題:	bone metastases bone‐modifying agent bone scan index bone scintigraphy denosumab mandible
オンライン･アクセス:	https://doi.org/10.1002/bco2.70212
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!